HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NPM1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors.

AbstractBACKGROUND:
Atypical teratoid/rhabdoid tumors (AT/RTs) are highly malignant brain tumors with inactivation of the SMARCB1 gene, which play a critical role in genomic transcriptional control. In this study, we analyzed the genomic and transcriptomic profiles of human AT/RTs to discover new druggable targets.
METHODS:
Multiplanar sequencing analyses, including whole exome sequencing (WES), single nucleotide polymorphism (SNP) arrays, array comparative genomic hybridization (aCGH), and whole transcriptome sequencing (RNA-Seq), were performed on 4 AT/RT tissues. Validation of a druggable target was conducted using AT/RT cell lines.
RESULTS:
WES revealed that the AT/RT genome is extremely stable except for the inactivation of SMARCB1. However, we identified 897 significantly upregulated genes and 523 significantly downregulated genes identified using RNA-Seq, indicating that the transcriptional profiles of the AT/RT tissues changed substantially. Gene set enrichment assays revealed genes related to the canonical pathways of cancers, and nucleophosmin (NPM1) was the most significantly upregulated gene in the AT/RT samples. An NPM1 inhibitor (NSC348884) effectively suppressed the viability of 7 AT/RT cell lines. Network analyses showed that genes associated with NPM1 are mainly involved in cell cycle regulation. Upon treatment with an NPM1 inhibitor, cell cycle arrest at G1 phase was observed in AT/RT cells.
CONCLUSIONS:
We propose that NPM1 is a novel therapeutic target for AT/RTs.
AuthorsJi Hoon Phi, Choong-Hyun Sun, Se-Hoon Lee, Seungmook Lee, Inho Park, Seung Ah Choi, Sung-Hye Park, Ji Yeoun Lee, Kyu-Chang Wang, Seung-Ki Kim, Hongseok Yun, Chul-Kee Park
JournalBMC cancer (BMC Cancer) Vol. 19 Issue 1 Pg. 848 (Aug 28 2019) ISSN: 1471-2407 [Electronic] England
PMID31462227 (Publication Type: Journal Article)
Chemical References
  • Indoles
  • NPM1 protein, human
  • NSC 348884
  • Nuclear Proteins
  • Nucleophosmin
Topics
  • Cell Cycle (drug effects)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Comparative Genomic Hybridization
  • Gene Expression Profiling (methods)
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Indoles (pharmacology)
  • Nuclear Proteins (genetics)
  • Nucleophosmin
  • Oligonucleotide Array Sequence Analysis
  • Polymorphism, Single Nucleotide
  • Rhabdoid Tumor (genetics)
  • Sequence Analysis, RNA
  • Teratoma (genetics)
  • Up-Regulation
  • Exome Sequencing (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: